BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cook, H L
Right arrow Articles by ffytche, T J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, H L
Right arrow Articles by ffytche, T J
British Journal of Ophthalmology 2002;86:1107-1108
© 2002 British Journal of Ophthalmology


SCIENTIFIC CORRESPONDENCE

Entonox as an analgesic agent during panretinal photocoagulation

H L Cook1, R S B Newsom1, E Mensah1, M Saeed1, D James2, T J ffytche1

1 Department of Ophthalmology, St Thomas’s Hospital, London, UK
2 Department of Anaesthesia, St Thomas’s Hospital, London, UK

Correspondence to:
Correspondence to:
Helen L Cook, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK;
HelenLCook{at}aol.com


ABSTRACT
Background/aims: Panretinal photocoagulation (PRP) reduces the risk of visual loss in proliferative diabetic retinopathy but some patients cannot tolerate PRP because of pain. Inhaled Entonox was evaluated as an analgesic during PRP.

Methods: A randomised, crossover, double masked pilot study was performed. Patients inhaled either air or Entonox and half the PRP was applied. The treatment was completed with the alternate inhaled gas. Patients graded pain experienced during both stages of the treatment using a visual analogue scale. Pain scores were compared using a paired t test.

Results: 20 patients participated. Mean pain scores from the Entonox and air treatments were 2.94 (SD 2.73) versus 3.73 (SD 3.20) respectively (p<0.03).

Conclusion: Entonox can be used as a safe and effective analgesic agent during PRP treatment.


Keywords: diabetic retinopathy; analgesia; Entonox; panretinal photocoagulation




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
D Vaideanu, P Taylor, P McAndrew, A Hildreth, J P Deady, and D H Steel
Double masked randomised controlled trial to assess the effectiveness of paracetamol in reducing pain in panretinal photocoagulation
Br. J. Ophthalmol., June 1, 2006; 90(6): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Ishikawa and R. M. Quock
Role of Nitric-Oxide Synthase Isoforms in Nitrous Oxide Antinociception in Mice
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 484 - 489.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
S Sandramouli and M Kurli
Entonox as an analgesic agent
Br. J. Ophthalmol., March 1, 2003; 87(3): 376 - 376.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd.